Commercial intelligence · New York

Menu

Market AwardsContracts and grants already awarded OpportunitiesRFPs and grants open now PolicyBills, laws, and regulations ProgramsNamed funding initiatives and who they fund CalendarUpcoming committee hearings and meetings

Network OfficialsEveryone holding public office in New York City and State OrganizationsPublic and civic sector organizations across New York LobbyingWho is registered to lobby, for which client, and for how much

Exchange Market structureWho funds a sector, how concentrated it is, and who is established Stakeholder mapThe offices whose remit intersects your work, mapped to your site Lobbying landscapeWho is already lobbying your space, the most-lobbied offices, and what representation costs DossiersOne reconciled file on any organization, agency, or official MonitorAlerts on new money, RFPs, and mentions you track Build a PlanA strategic plan customized for you

About Hire a consultant ↗

Sign in Get Pro

Build my strategy

$1,000The New York strategy we build for retained clients, made accessible.Build my strategy →

New York policy

S8569: Relates to dispensing certain individuals with opioid reversal drugs upon discharge

NY Senate · Sponsor James Sanders Jr.

Watch this bill · sign in

ShareLinkedIn ↗Email

Jurisdiction: New York State
Applies to: New York State (proposed)
Effective: January 7, 2026

What it requires

Requires inpatient facilities to dispense at-risk individuals with opioid reversal drugs upon discharge.

ny-statesenatelegislationbill

Official source ↗

Free account

Create a free account

Track New York policy and save searches across the Network. Free. No card required.

Continue with Google Continue with LinkedIn

or email

Want to turn policy like this into market and network moves? Build your Market Network Strategic Plan →